TRANSAPICAL TRANSCATHETER AORTIC VALVE IMPLANTATION IN A HIGH-RISK PATIENT WITH AORTIC AND MITRAL REGURGITATION: USAGE OF THE JENAVALVE™ SYSTEM

SULEYMAN SURER, ILKER INCE, IBRAHİM DUVAN, CENGİZHAN BAYYURT, UGURSAY KİZİLTEPE

The European Research Journal - 2016;2(3):219-221

Department of Cardiovascular Surgery, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey

 

JenaValveTM system is a second-generation transcatheter heart valve that provides a successful deployment not only in calcified stenotic aortic valves but also in non-calcified, severe regurgitant aortic valves. We performed a transapical transcatheter aortic valve implantation procedure using this system without any procedure-related complications in a 75-year-old woman with multiple co-morbidity factors, who had both mitral and aortic regurgitation, and low ejection fraction.